July 27, 2016
The Mexican Acromegaly Registry, the first non-European registry of the disease and the largest such registry in the world, shows that the availability of resources influences treatment choices in different parts of Mexico, according to researchers.
“The Mexican Acromegaly Epidemiology Program constitutes the largest registry of the disease reported to date and the first to be established in a non-European country,” Lesly A. Portocarrero-Ortiz, MD, of the Instituto Nacional de Neurologia y Neurocirugia, Mexico City, and colleagues wrote. “Our clinical, biochemical and therapeutic outcome data is roughly similar to that reported by the different European registries. Yet, our results reveal significant interinstitutional variations derived from the different availabilities of resources to treat this disease.”